Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02755493 · ClinicalTrials.gov registry record · NA

Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control

A NA study of Sleep Deprivation, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT02755493 is a NA study of Sleep Deprivation that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 22 participants, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02755493, a NA study of Sleep Deprivation, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This project proposes to both develop and test adaptive automation countermeasures for the effects of stressors such as sleep deprivation (SD) on human performance related to robotic tasks, and investigate the relationship between human trust and appropriate use of these countermeasures.

Conditions Studied

Interventions

  • BEHAVIORAL Sleep deprivation

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-04
Est. Completion 2018-05-31
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT02755493

The ClinicalTrials.gov registry entry for NCT02755493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (76% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Deprivation appearing as the primary indexed condition, and to 1 intervention - of which Sleep deprivation is the first listed.

NCT02755493 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02755493 about?

NCT02755493 is a clinical study titled "Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control". This project proposes to both develop and test adaptive automation countermeasures for the effects of stressors such as sleep deprivation (SD) on human performance related to robotic tasks, and investigate the relationship between human trust and appropriate use of these countermeasures.

What is the current status of trial NCT02755493?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-04. Estimated completion is 2018-05-31.

What conditions does trial NCT02755493 study?

This clinical trial studies the following conditions: Sleep Deprivation.

What interventions are being tested in trial NCT02755493?

The interventions under investigation include: Sleep deprivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02755493?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02755493 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Deprivation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.